Driving CAR-T Manufacture Optimization through Technology Innovation
Cell & Gene Therapy Insights Latest advances in CAR-T cell manufacture & clinical developments PHILIP H COELHO, Founder and Chief Technology Officer (CTO) of ThermoGenesis Corp., the device Division of Cesca Therapeutics (is an engineer/inventor, educated at the University of California, Davis, where he specialized in thermodynamics and machine design. He has been awarded more … Continued